Zobrazeno 1 - 10
of 64
pro vyhledávání: '"R. Kruitwagen"'
Autor:
R. Kruitwagen, Charlotte P. R. Triepels, Dorothea M. Koppes, Toon Van Gorp, Kim J. B. Notten, Fedde Scheele, Annelieke N. Schepens-Franke
Publikováno v:
Koppes, D M, Triepels, C P R, Schepens-Franke, A N, Kruitwagen, R F P M, Van Gorp, T, Scheele, F & Notten, K J B 2020, ' What do we need to know about anatomy in gynaecology : A Delphi consensus study ', European Journal of Obstetrics and Gynecology and Reproductive Biology, vol. 245, pp. 56-63 . https://doi.org/10.1016/j.ejogrb.2019.11.015
European Journal of Obstetrics and Gynecology and Reproductive Biology, 245, 56-63. Elsevier Ireland Ltd
European Journal of Obstetrics & Gynecology and Reproductive Biology, 245, pp. 56-63
European Journal of Obstetrics & Gynecology and Reproductive Biology, 245, 56-63
European Journal of Obstetrics & Gynecology and Reproductive Biology, 245, 56-63. Elsevier
European Journal of Obstetrics and Gynecology and Reproductive Biology, 245, 56-63. Elsevier Ireland Ltd
European Journal of Obstetrics & Gynecology and Reproductive Biology, 245, pp. 56-63
European Journal of Obstetrics & Gynecology and Reproductive Biology, 245, 56-63
European Journal of Obstetrics & Gynecology and Reproductive Biology, 245, 56-63. Elsevier
Contains fulltext : 225410.pdf (Publisher’s version ) (Closed access) Objective: Determination of the anatomical structures that should be taught to ensure safe and competent practice among general gynaecologists. Study Design: A two-round Delphi s
Autor:
Petra L.M. Zusterzeel, T Van Gorp, J Van Der Pol, P Laven, B Slangen, R. Kruitwagen, S. Lambrechts
Publikováno v:
E-Posters.
Autor:
Michel W.J.M. Wouters, N.M.S. Baldewpersad Tewarie, T Hogberg, M. van Ham, W.J. van Driel, R Rome, C Høgdall, R Kruitwagen, E Pagano
Publikováno v:
E-Posters.
Autor:
R L, van der Horst, O, van der Hel, L, Lutgens, M, van der Aa, B, Slangen, R, Kruitwagen, R I, Lalisang
Publikováno v:
Critical Reviews in Oncology/Hematology. 175:103701
The uterine carcinosarcoma (UCS) is a rare entity with poor prognosis. Treatment of FIGO I-II UCS usually consists of surgery with or without adjuvant treatment. Due to the high metastatic potential, aggressive combined modality adjuvant treatment ap
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Incomplete surgical staging in clinical early-stage ovarian cancer: guidelines versus daily practice
Autor:
M. Van Der Aa, MC Vos, T Van Gorp, D. Boll, J B Trimbos, N. Reesink, J E Bense, Hgj Arts, P Laven, J.J. Beltman, R Kruitwagen
Publikováno v:
Surgery Open Science
Surgery Open Science, 7, 6-11. Elsevier BV
Surgery Open Science, Vol 7, Iss, Pp 6-11 (2022)
Surgery open science, 7, 6-11. Elsevier
Surgery Open Science, 7, 6-11. Elsevier BV
Surgery Open Science, Vol 7, Iss, Pp 6-11 (2022)
Surgery open science, 7, 6-11. Elsevier
BACKGROUND: Incomplete surgical staging of patients with early-stage epithelial ovarian cancer (EOC) has been reported in up to 98% of cases, when based on the International Federation of Obstetrics and Gynecology (FIGO) staging procedure. The aim of
Autor:
S. Vrede, J. Kasius, J. Bulten, W.J. Van Weelden, D. Boll, M.C. Vos, A. Van Altena, X. Matias-Guiu, J. Asberger, E. Colas, A. Gil-Moreno, J. Huvila, V. Weinberger, F. Amant, M. Snijders, H. Küsters-Vandevelde, A. Eijkelenboom, R. Kruitwagen, C. Reijnen, J.M. Pijnenborg
Publikováno v:
Annals of Oncology. 33:S392
Autor:
MC Vos, H.T.C. Nagel, R.A. Smit, N. Reesink, A. Baalbergen, Eva Maria Roes, P.J. Timmers, Arnold-Jan Kruse, Jan Willem M. Mens, Mirjam J. A. Engelen, B.A.J.T. Visschers, T.C. Stam, H.P.M. Smedts, N.M.S. Baldewpersad Tewarie, A. van der Kolk, J. Lange, H. Verhoeve, Katja N. Gaarenstroom, Michel W.J.M. Wouters, Brigitte F. M. Slangen, I. Ebisch, Sjors F.P.J. Coppus, D. Boll, L. Hofman, C. G. Gerestein, Y.W.C.M. van der Plas-Koning, J. de Waard, A.M.L.D. van Haaften-de Jong, E.B.L. van Dorst, J. Diepstraten, A.D. Ten Cate, M.Y. Tjiong, M.A. van der Aa, R. Yigit, A.L. Aalders, R Kruitwagen, J. Briet, W.J. van Driel, M. van Ham, P.M.L.H. Vencken, M.B. Verbruggen, M. Huisman, Guus Fons
Publikováno v:
Gynecologic Oncology, 162(2), 331-338. Elsevier Science
Gynecologic Oncology, 162, 2, pp. 331-338
Gynecologic Oncology, 162, 331-338
On behalf of the participants of the Dutch Gynecological Oncology Collaborator Group 2021, ' Postoperative outcomes of primary and interval cytoreductive surgery for advanced ovarian cancer registered in the Dutch Gynecological Oncology Audit (DGOA) ', Gynecologic Oncology, vol. 162, no. 2, pp. 331-338 . https://doi.org/10.1016/j.ygyno.2021.05.030
Gynecologic oncology, 162(2), 331-338. Academic Press Inc.
Gynecologic Oncology, 162(2), 331-338. Academic Press Inc.
Gynecologic Oncology, 162(2), 331-338. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic Oncology, 162(2), 331-338. Academic Press
Gynecologic Oncology, 162, 2, pp. 331-338
Gynecologic Oncology, 162, 331-338
On behalf of the participants of the Dutch Gynecological Oncology Collaborator Group 2021, ' Postoperative outcomes of primary and interval cytoreductive surgery for advanced ovarian cancer registered in the Dutch Gynecological Oncology Audit (DGOA) ', Gynecologic Oncology, vol. 162, no. 2, pp. 331-338 . https://doi.org/10.1016/j.ygyno.2021.05.030
Gynecologic oncology, 162(2), 331-338. Academic Press Inc.
Gynecologic Oncology, 162(2), 331-338. Academic Press Inc.
Gynecologic Oncology, 162(2), 331-338. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic Oncology, 162(2), 331-338. Academic Press
Objectives. The challenge when performing cytoreductive surgery (CRS) is to balance the benefits and risks. The aim of this study was to report short term postoperative morbidity and mortality in relation to surgical outcome in patients undergoing pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ea3ca6a5e9699a01b8fa682b8f2669f
https://doi.org/10.1016/j.ygyno.2021.05.030
https://doi.org/10.1016/j.ygyno.2021.05.030
Autor:
AM van Altena, S Said, Sabine Siesling, J.A. de Hullu, Gabe S. Sonke, M. Van Der Aa, R. Bretveld, R Kruitwagen, Hendrik Koffijberg
Publikováno v:
Oral Poster – TAPED.
Objective To identify clinicopathologic factors predictive of early relapse (i.e. a platinum-free interval (PFI) of ≤6 months) in advanced epithelial ovarian cancer (EOC) in first-line treatment, and to develop and internally validate risk predicti
Publikováno v:
Poster.
Objective Sentinel lymph node (SLN) detection in ovarian cancer is feasible when tracers are injected before the pathological ovary is resected. This study aims to investigate whether the SLN identification is also feasible in patients whose ovarian